Henry Schein, Inc.
HSIC Healthcare Medical Distribution
Henry Schein, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.2 billion, up 4.03% from fiscal 2024. In the quarter to June 2026, revenue grew 6.73%, EPS grew 16.9%, free cash flow grew 140.9% and total debt rose 15.2%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.
Follow HSIC
Henry Schein, Inc. (HSIC) Free cash flow
Henry Schein, Inc.'s free cash flow for fiscal 2025 was $573.0M, down 18.1% from $700.0M in fiscal 2024. Over the twelve months to 30 June 2026 it was $569.0M. Over the past ten years it has ranged from $353.0M (fiscal 2023) to $700.0M (fiscal 2024); the current reading is higher than 64% of that period. Henry Schein, Inc. ranks 4th of 11 Medical Distribution companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $573.0M | (18.14%) |
| FY2024 | $700.0M | 98.30% |
| FY2023 | $353.0M | (30.24%) |
| FY2022 | $506.0M | (19.81%) |
| FY2021 | $631.0M | 14.73% |
| FY2020 | $550.0M | (4.82%) |
| FY2019 | $577.9M | (5.80%) |
| FY2018 | $613.4M | 26.97% |
| FY2017 | $483.1M | (15.60%) |
| FY2016 | $572.4M | 5.26% |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Jun 2026 | $212.0M | — |
| Mar 2026 | −$122.0M | — |
| Dec 2025 | $338.0M | 139.72% |
| Sep 2025 | $141.0M | 60.23% |
| 42 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| MCK McKesson Corporation compare | $6.1B |
| CAH Cardinal Health, Inc. compare | $4.6B |
| COR Cencora, Inc. compare | $4.1B |
| HSIC Henry Schein, Inc. | $569.0M |
| HKPD Cellyan Biotechnology Co., Ltd compare | $144.2K |
| COSM Cosmos Health Inc. compare | −$12.5M |
| FOCL FocalTherics compare | −$19.1M |
| AHG Akso Health Group Sponsored ADR compare | −$160.2M |
| ACH Accendra Health, Inc. compare | −$210.9M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on HSIC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement